10x Genomics Inc Ordinary Shares - Class A (TXG)

Industry Health Information Services


This stock can be held in an Investment ISA and an Investment Account
Sell

$9.20

Buy

$9.21

arrow-up$0.08 (+0.88%)

Prices updated at 15 May 2025, 21:12 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Income statement

20232024
619m611m
409m414m
-204m-195m
-33.03-31.85
-255m-183m
-205m-134m
Sales, General and administrative343m344m
Interest expenses33,0004,000
Provision for income taxes6m5m
Operating expenses614m609m
Income before taxes-249m-178m
Net income available to common shareholders-255m-183m
-2.18-1.52
Net interest income17m18m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-2.18-1.52
Free cash flow per share-0.97270.2092
Book value/share6.25735.9105
Debt equity ratio0.113150.103258

Balance sheet

20232024
Current assets596m584m
Current liabilities127m118m
Total capital741m710m
Total debt95m83m
Total equity741m710m
Total non current liabilities--
Loans--
Total assets965m919m
Total liabilities--
Cash and cash equivalents359m344m
Common stock119m122m

Cash flow

20232024
Cash at beginning of period227m359m
Cash dividends paid--
-65m-7m
Investments (gains) losses133m-33m
359m344m
Net income--
-15m7m
-50m-13m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.